Cantel Medical Corp. (CMN)

EBStroke (< 20) Submitted: 10/27/2009 11:58:34 AM : Start Price: $16.23 CMN Score: +8.77

Zacks Rank 1-StrongBuy, Recommend Outperform, Industry Rank 86 / 217, Target 18.40, Avg Target of 2 analysts 22.50

Ayax2006 (99.02) Submitted: 10/5/2009 2:06:36 AM : Start Price: $15.40 CMN Score: +10.72

Cantel Medical Corp. provides infection prevention and control products for the healthcare market primarily in the United States. It operates in six segments: Water Purification and Filtration, Dialysis, Healthcare Disposables, Endoscope Reprocessing, Therapeutic Filtration, and Specialty Packaging. Short term play on H1N1, long term play on aging populations and increased spending on healthcare and infection prevention, not too mention water purification needs. Attractive valuation.

physicsisphun (56.46) Submitted: 7/2/2009 11:58:36 PM : Start Price: $15.04 CMN Score: -4.02

This looks like a very good entry point on this stock. it dropped 7% Thursday, but it's had 4 straight quarters of (large!) earnings surprises, and excellent growth of earnings, plus recent momentum in earnings estimates. It makes no sense that this stock is where it is. It is not widely followed, but I'd expect that to change.

Teknowizz (88.04) Submitted: 5/16/2009 4:40:09 AM : Start Price: $13.28 CMN Score: +12.28

Great fundamentals, especially strong cash-flow (quite important now of course) & it's a medical stock, which is also good to have as that is recession proof.
Thumbs up.

jbeavers14 (86.08) Submitted: 10/11/2008 12:32:16 AM : Start Price: $10.78 CMN Score: +48.99

I am big believer in any company that is associated with the medical industry because that company should always have something to sell and someone to buy.

CerealBoxGangsta (< 20) Submitted: 8/7/2008 9:45:00 PM : Start Price: $9.35 CMN Score: +105.14

Smart company moving to US from abroad. Maybe ALU should think about the same.

JohnnyiPhone (< 20) Submitted: 6/13/2008 8:34:18 AM : Start Price: $11.31 CMN Score: +76.10

Member of the "Mini-Cap Monsters."

NetscribeMedDevs (91.00) Submitted: 3/20/2007 8:09:53 AM : Start Price: $15.71 CMN Score: +32.55

Cantel Medical Corp. is a leading provider of infection prevention and control products in the healthcare market. The company operates through four subsidiaries including Minntech, Crosstex, Mar Cor Purification and Saf-T-Pak. The company operates in six different segments through these subsidiaries which are: Dialysis, Endoscope Reprocessing and Therapeutic Filtration which are operated through Minntech, Dental operating segment operated through Crosstex, Water Purification and Filtration operated through Mar Cor Purification and Specialty Packaging operated through Saf-T-Pak.

The company recently reported 9% increase in its revenues for the second quarter of 2007 as compared to the same period in 2006. The company divested the Carsen, its Canadian endoscope distribution business and is now fully focused on maintaining its leadership in infection prevention and control. It also recently entered into a distribution agreement for the MDS in the United Kingdom which is expected to increase its sales coverage and reduce operating costs. Additionally, with the shift in product mix achieved by the company over the past two quarters, over two-thirds of the company’s revenues are now recurring in nature.

According to a research over 2.5 million people acquire an infection while in the care of a US healthcare facility every year costing the US healthcare system more than 5.5 billion annually. Additionally with an increased recurrence of drug-resistant staph infections otherwise know as MRSA or super-bugs and the threat of avian flu and bio terrorism offer tremendous opportunities for Cantel in the future. Moreover with the aging of the population in the US and developing countries, procedure growth continues in the endoscopy market which bodes well for the endoscope reprocessing business. Through the innovation of proprietary products and continued acquisitions, the company is well positioned to cash on these opportunities and it is expected that it will please the investors by its performance in the future.

YoungScientist63 (83.88) Submitted: 1/20/2007 10:23:05 AM : Start Price: $16.40 CMN Score: -29.08

Even though I like medical stocks, I don't think this one is a winner. :( --A Scientist

DarthTater (44.73) Submitted: 12/29/2006 7:50:28 AM : Start Price: $16.85 CMN Score: +25.50

Perhaps all the bad news has already been factored in? Bit of a contrarian play here. Above the 200 day MA and has put in some strong up days.

fibreoptik (88.84) Submitted: 12/23/2006 5:44:37 AM : Start Price: $16.97 CMN Score: +24.00

New management, balance is not as bad as all these naysayers are putting forth... Give them a chance to recover, these guys are going to see more product/service orders over the next 5-10, demographics people - demographics! (hint: old people are not getting any younger)

liberty458 (< 20) Submitted: 12/7/2006 10:33:15 PM : Start Price: $16.10 CMN Score: +30.01

i believe this one will outperform

FMW108 (87.31) Submitted: 11/30/2006 1:32:40 PM : Start Price: $13.95 CMN Score: +47.32

I can't think of any bad news for Cantel. The services they provide are in demand. I will hold this for another 6 - 9 months.

antigenics1 (< 20) Submitted: 10/13/2006 10:05:59 AM : Start Price: $12.60 CMN Score: +58.56

I want to watch them after the bad report

skc0001 (< 20) Submitted: 10/4/2006 7:47:57 AM : Start Price: $13.65 CMN Score: +45.31

A value proposition